K W Somerville

1.7k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

K W Somerville is a scholar working on Surgery, Pharmacology and Epidemiology. According to data from OpenAlex, K W Somerville has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in K W Somerville's work include Inflammatory mediators and NSAID effects (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). K W Somerville is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). K W Somerville collaborates with scholars based in United Kingdom. K W Somerville's co-authors include M. J. S. Langman, Gail Faulkner, M J Langman, M Edmond, C J Hawkey, Richard F. Logan, RF Logan, Christopher J. Hawkey, G. D. Bell and K R Hine and has published in prestigious journals such as The Lancet, Gut and The American Journal of Medicine.

In The Last Decade

K W Somerville

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER

1986 429 citations K W Somerville, Gail Faulkner et al. The Lancet profile →

Peers

Countries citing papers authored by K W Somerville

Since Specialization

Citations

This map shows the geographic impact of K W Somerville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K W Somerville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K W Somerville more than expected).

Fields of papers citing papers by K W Somerville

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K W Somerville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K W Somerville. The network helps show where K W Somerville may publish in the future.

Co-authorship network of co-authors of K W Somerville

This figure shows the co-authorship network connecting the top 25 collaborators of K W Somerville. A scholar is included among the top collaborators of K W Somerville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K W Somerville. K W Somerville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modeling disease elimination. 2005 ·PubMed ·K W Somerville, (unknown)	3
2	Apoptosis Induction and Inhibition of Colon-26 Tumour Growth and Angiogenesis: Findings On COX-1 and COX-2 Inhibitors in Vitro & in Vivo and Topical Diclofenac in Hyaluronan 1997 ·Advances in experimental medicine and biology ·Michael Seed, (unknown), (unknown), Paul Colville‐Nash, Joanne R. Brown, (unknown), K W Somerville, D. A. Willoughby	23
3	Non-steroidal anti-inflammatory drugs: is the balance shifting? 1997 ·Age and Ageing ·K W Somerville, (unknown)	3
4	Endocarditis due to high level gentamicin resistant Enterococcus faecium 1994 ·Journal of Infection ·(unknown), J R Anderson, (unknown), K W Somerville	8
5	Aspirin and bleeding peptic ulcers in the elderly. 1988 ·BMJ ·Gail Faulkner, (unknown), K W Somerville, M. J. S. Langman	86
6	Prophylaxis of aspirin‐induced gastric mucosal bleeding with ranitidine 1988 ·Alimentary Pharmacology & Therapeutics ·Christopher J. Hawkey, K W Somerville, Samuel F. Marshall	29
7	Twenty‐four‐hour intragastric acidity and clinical trial of bedtime enprostil 70 μg compared with ranitidine 300 mg in duodenal ulcer 1987 ·Alimentary Pharmacology & Therapeutics ·R P Walt, R E Pounder, Christopher J. Hawkey, (unknown), K W Somerville, Richard F. Logan, Richard Long, M J Langman	15
8	Effect of famotidine on oxidative drug metabolism 1986 ·European Journal of Clinical Pharmacology ·K W Somerville, (unknown), M J Langman	20
9	Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa 1986 ·The American Journal of Medicine ·Christopher J. Hawkey, (unknown), K W Somerville	38
10	Non-steroidal anti-inflammatory agents and the gastrointestinal tract 1986 ·Postgraduate Medical Journal ·K W Somerville, C J Hawkey	50
11	NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER breakdown → 1986 ·The Lancet ·K W Somerville, Gail Faulkner, M. J. S. Langman	429
12	Effect of treatment on symptoms and quality of life in patients with ulcerative colitis: comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas. 1985 ·BMJ ·K W Somerville, M J Langman, S. P. Kane, A.J. MacGilchrist, G Watkinson, Paul Salmon	32
13	Stones in the common bile duct: experience with medical dissolution therapy 1985 ·Postgraduate Medical Journal ·K W Somerville, (unknown), (unknown), T.W. Balfour, G. D. Bell	22
14	SOMATOSTATIN IN TREATMENT OF HAEMATEMESIS AND MELAENA 1985 ·The Lancet ·K W Somerville, (unknown), C J Hawkey, David Henry, K R Hine, M. J. S. Langman	65
15	Smoking and Crohn's disease. 1984 ·BMJ ·K W Somerville, Richard F. Logan, M Edmond, M J Langman	165
16	Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation. 1984 ·BMJ ·(unknown), K W Somerville, (unknown), G. D. Bell	26
17	Malignant transformation of anal skin tags in Crohn's disease. 1984 ·Gut ·K W Somerville, M J Langman, (unknown), T.W. Balfour, (unknown)	20
18	Smoking and ulcerative colitis. 1984 ·BMJ ·RF Logan, M Edmond, K W Somerville, M. J. S. Langman	96
19	Newer Antisecretory Agents for Peptic Ulcer 1983 ·Drugs ·K W Somerville, M J Langman	17
20	Mechanisms for Adjuvant Cholelitholytic Properties of the Monoterpene Mixture Rowachol (R) 1981 ·Clinical Science ·(unknown), G. D. Bell, K W Somerville, Richard J. Clegg, B. Middleton, David A. White	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact